Y-27632 2HCl

製品コードS1049

Y-27632 2HCl化学構造

分子量(MW):320.26

Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK.

サイズ 価格(税別)  
JPY 25896.00
JPY 11620.00
JPY 19920.00
JPY 28220.00
JPY 94620.00

文献中の使用例(48)

カスタマーフィードバック(5)

  • The ROCK inhibitors fasudil and Y27632 prevented SCP2 cell bone metastasis in nude mice (n = 10 per group). Shown are BLI images of bone metastases, IHC analyses of SMAD3 C-tail phosphorylation and PTHLH, osteoclast TRAP staining, and BLI quantitation.

    J Clin Invest, 2014, 124(4): 1646-59. Y-27632 2HCl purchased from Selleck.

    YAP nuclear localization in fibroblasts treated with PRP-Exos was blocked by Y-27632 2HCl. Scale bar: 50 μm.

    Theranostics, 2017, 7(1):81-96. Y-27632 2HCl purchased from Selleck.

  • The Rho GTPase-JNK pathway is required for the inhibitory effects of vandetanib on Calu-6 cells invasion. Calu-6 cells were incubated for 24 h in the presence or absence of vandetanib (1 or 2 uM), SP600125 (50 or 100 uM), and Y27632 (5 or 10 uM). The morphology of the Calu-6 cells was examined under a light microscope. Scale bar: 50 um.

    Mol Neurobiol 2015 10.1007/s12035-014-9084-z. Y-27632 2HCl purchased from Selleck.

    Effect of mechanical strain on cell morphology. (A) SEM analyses indicate that strain-induced cell elongation is prevented by treatment with HA1100 and Y27632. (B) Quantification of cellular area in the indicated conditions (n = 20). (C) F-actin staining of control, strained and HA1100 or Y27632-treated cells attests that inhibition of RhoA/ROCK prevents mechanical strain-induced cell elongation. *p < 0.05 compared to control without strain (CTL).

    J Mol Cell Cardiol 2014 67, 49-59. Y-27632 2HCl purchased from Selleck.

  • Dev Biol 2012 370, 33-41. Y-27632 2HCl purchased from Selleck.

製品安全説明書

ROCK阻害剤の選択性比較

生物活性

製品説明 Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK.
ターゲット
ROCK1 (p160ROCK) [1]
(Cell-free assay)
ROCK2 [6]
(Cell-free assay)
140 nM(Ki) 300 nM(Ki)
体外試験

Y-27632 2HCl inhibits ROCK-II while displaying little activity against PKC, cAMP-dependent protein kinase and myosin light-chain kinase (MLCK) with Ki of 26 μM, 25 μM and > 250 μM, respectively, as well as PKA activated by another Rho-family GTPase member, Cdc42. Y-27632 2HCl inhibits smooth-muscle contraction induces by various agonists including phenylephrine, histamine, acetylcholine, serotonin, endothelin, and thromboxane with IC50 of 0.3-1 μM, by selectively inhibiting Ca2+ sensitization. Y-27632 2HCl suppresses Rho-induced, p160ROCK-mediated formation of stress fibres in cultured cells. [1] Y-27632 2HCl treatment blocks both Rho-mediated activation of actomyosin and LPA-stimulated invasive activity of MM1 cells in a concentration-dependent manner. [2] Y-27632 2HCl treatment is not only sufficient to initiate formation of exuberant axonal processes but also facilitates axonal maturation during the very early stages of axonogenesis, while largely sparing axon elongation. [3] In human embryonic stem (hES) cells, Y-27632 2HCl treatment at 10 μM markedly diminishes dissociation-induced apoptosis even in serum-free suspension (SFEB) culture, increases cloning efficiency (from ~1% to ~27%), facilitates subcloning after gene transfer, and enables SFEB-cultured hES cells to survive and differentiate into Bf1+ cortical and basal telencephalic progenitors. [4]

細胞データ
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Swiss 3T3 cells NHnDSI9HfW6ldHnvckBCe3OjeR?= NHezcW4yOCEQvF2= MYSyJIg> NGnoW4hFVVOR NXH5UXVmUW6qaXLpeJMhfGinIHHzd4Vu[my7IH;mJI1q[3KxdIXieYxmeyCjbnSgbY51\XKvZXTpZZRmKG[rbHHt[Y51eyC2bzDmc5JuKGW6dHXu[IVlKHC{b3Pld5Nmew>? M4XJVlk3PDd4NUS=
N1E-115 MX\GeY5kfGmxbjDBd5NigQ>? M3ziXlExKM7:TR?= MmjYNkBp MnLmSG1UVw>? MmXrTY5pcWKrdIOgeIhmKGG|c3XtZox6KG:oIH3pZ5JwfHWkdXzld{BidmRiaX70[ZJu\WSrYYTlJIZqdGGvZX70d{B1dyCob4LtJIV5fGWwZHXkJJBzd2Onc4Pldy=> M1zUXlk3PDd4NUS=
HeLa NYHufZFWTnWwY4Tpc44hSXO|YYm= M{\G[VExKM7:TR?= NIHOcFg{OCCvaX6= M4HiNGlvcGmkaYTzJJRp\SCob4LtZZRqd25ib3[gd5Rz\XO|IH\pZoVzeyCjbnSgeIhmKGG|c3XtZox6KG:oII\pcoN2dGmwLXPvcpRicW6rbneg[o9k[WxiYXTo[ZNqd26| MXq5OlY5ODd{
CCL39 M{Lsb2Z2dmO2aX;uJGF{e2G7 MVizNEDPxE1? NGjUXI0{OCCvaX6= MXvDc41xdGW2ZXz5JIFjd2yrc3jld{Bi[3SrdnH0bY9vKG:oIF7hMWgh\XilaHHu[4VzKE6KRUGgZpkhcW62ZXfybY5{ M2DYbFk3QTN|OEK=
Mesothelial cells from rat mesentery NX:0R4h1UW64YYPpeoUhSXO|YYm= NXTXSIM5OzBizszN MmDTNlAhcA>? NVPtcHpQSmyxY3vzJIlvfmG|aY\lJIFkfGm4aYT5 MknyPVk{ODh5Mh?=
NIH3T3 M{LaO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn3vNVAh|ryP M4\6SFE5KGR? Ml\oSI9meyCwb4SgbY5pcWKrdDDj[YxtKGe{b4f0bC=> NEX3NIsyODB{MUO4Oi=>
Dbl-d M{PKSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7LNVAh|ryP MkToNVgh\A>? MWHTeJJwdmeueTDpcohq[mm2czDj[YxtKGe{b4f0bC=> MYixNFAzOTN6Nh?=
Dbl-e M{DNO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{\rbVExKM7:TR?= NXe5V3BlOThiZB?= MnL6UY9l\XKjdHXsfUBqdmirYnn0d{Bk\WyuIHfyc5d1cA>? NVrZXWlKOTByMkGzPFY>
mNET1-d NU\tXHVRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1:3TFExKM7:TR?= MW[xPEBl MnrXV5Rzd26pbImgbY5pcWKrdIOgZ4VtdCCpcn;3eIg> NFfBdI8yODB{MUO4Oi=>
mNET1-e MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml3VNVAh|ryP NY\veGtNOThiZB?= NUDwZpE{W3S{b37ncJkhcW6qaXLpeJMh[2WubDDndo94fGh? NGPI[HoyODB{MUO4Oi=>
Ras-2 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYCxNEDPxE1? M2rEUlE5KGR? MYfTeJJwdmeueTDpcohq[mm2czDj[YxtKGe{b4f0bC=> NEflU5UyODB{MUO4Oi=>
Ras-4 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2TneVExKM7:TR?= M37qUlE5KGR? M2[0SnN1em:wZ3z5JIlvcGmkaYTzJINmdGxiZ4Lve5Rp MYWxNFAzOTN6Nh?=
Src-1 M13COWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mkf1NVAh|ryP NIe0fnoyQCCm NFP2XXJFd2W|IH7veEBqdmirYnn0JINmdGxiZ4Lve5Rp MV2xNFAzOTN6Nh?=
Src-4 NXzIeYlnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH\GflQyOCEQvF2= M37VdlE5KGR? NGjKdJZFd2W|IH7veEBqdmirYnn0JINmdGxiZ4Lve5Rp NYLIR|Z6OTByMkGzPFY>
NIH3T3 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXTQco1ROTBizszN M4jv[lE5KGR? M1\5SGRw\XNibn;0JIlvcGmkaYSgZ4VtdCCpcn;3eIg> NVjLfFVJOTByMkGzPFY>
Src-1 NWHPPVZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnK4NVAh|ryP MYGxPEBl NIXIXZZFd2W|IH7veEBqdmirYnn0JINmdGxiZ4Lve5Rp NUX0WmR1OTByMkGzPFY>
Src-2 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkPxNVAh|ryP M3;rc|E5KGR? NHz3fnBFd2W|IH7veEBqdmirYnn0JINmdGxiZ4Lve5Rp M1;xNVExODJzM{i2
SW620 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nsW|ExKM7:TR?= NHPVW3cyQCCm M1O2WWRw\XNibn;0JIlvcGmkaYSgZ4VtdCCpcn;3eIg> MlT1NVAxOjF|OE[=
HCT15 Ml;VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mm\5NVAh|ryP NY\mUJE3OThiZB?= MVLEc4V{KG6xdDDpcohq[mm2IHPlcIwh\3Kxd4To MlvNNVAxOjF|OE[=
HCT116 NIWxV5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3To[FExKM7:TR?= NW\sUJNrOThiZB?= NGrKcoJUfHKxbnfsfUBqdmirYnn0d{Bk\WyuIHfyc5d1cA>? MYexNFAzOTN6Nh?=
LS174T MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2P4V|ExKM7:TR?= Mn7DNVgh\A>? M4XRfm1w\GW{YYTlcJkhcW6qaXLpeJMh[2WubDDndo94fGh? Mlj6NVAxOjF|OE[=
Neonatal rat ventricular myocytes M1[wSGZ2dmO2aX;uJGF{e2G7 MmL4NVAh|ryP NXfjWmlUPDhiaB?= NGnreJFKdmirYnn0d{BGXC1zLXnu[JVk\WRiaX7jdoVie2W|IHnuJJBzd3SnaX6gd5lvfGinc3nzMEBk\WyuIIPpfoUh[W6mIH35c4Zq[nKrbHzhdkBwemejbnn6ZZRqd25? MUixNFM5PjZzMx?=
Stellate Cell MVfGeY5kfGmxbjDBd5NigQ>? NYTqZ5JHOjVizszN NGrKe2IyPSCvaX6= NF7IWnhKdmirYnn0d{Bnd3KvYYTpc44hd2ZiRj3hZ5RqdiC|dILld5Mh\mmkZYLzJIFv\CCyaH;zdIhwenmuYYTpc44hd2ZibYnvd4lvKGyrZ3j0JINp[Wmw MkPvNVA3ODB2OU[=
Rat Vascular Smooth Muscle Cells NWLGOlFFTnWwY4Tpc44hSXO|YYm= M3f4dlExKM7:TR?= NYfRdGFSOiCq M4P5UmlvcGmkaYTzJIFv\2mxdHXud4lvKEmLLXnu[JVk\WRiaInw[ZJ1em:yaIm= NFLqVJAyODZ2MkOxOy=>
PC3 M3vodmZ2dmO2aX;uJGF{e2G7 MkToNlUh|ryP M1;MNVEhcA>? M3[xfWlv\HWlZYOgcY9zeGixbH;nbYNidCClaHHu[4V{ MX6xNFczODR5MR?=
PC3 MlOwUYloemG2aX;uJGF{e2G7 M3T5XVI2KM7:TR?= NVe5WplSOSCq M{XXOmlvcGmkaYTzJJRp\SCETV\CMWNOKGGwZDD0bIUhTUeILYP0bY12dGG2ZXSgcYloemG2aX;u NHXUV3UyODd{MES3NS=>
PC3 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVGyOUDPxE1? MkjjNVchcA>? MUTEc4V{KG6xdDDpcohq[mm2IHPlcIwh\3Kxd4To M3;POlExPzJyNEex
LNCaP MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWmyOUDPxE1? NFv5eYMyPyCq NE\wOY5Fd2W|IH7veEBqdmirYnn0JINmdGxiZ4Lve5Rp NXTU[IRXOTB5MkC0O|E>
Rat hepatic stellate cells M3fxdWZ2dmO2aX;uJGF{e2G7 NXXXTWRZOzBizszN M{TXXlQ5KGh? NITQenJFcW2rbnnzbIV{KHSqZTDwbI9{eGixconsZZRqd25ib3[gSZJsOixiYX7kJIRm[3KnYYPld{Bv\XdiRF7BJJN6dnSqZYPpdy=> M3\Hc|ExQDR3Nk[z
Pancreatic acinar cells M3HBXWZ2dmO2aX;uJGF{e2G7 MWGxNOKh|ryP M3;zNVcxKG2rbh?= Ml2yVI91\W62aXH0[ZMhS0ONLYP0bY12dGG2ZXSgdIFv[3KnYYTpZ{Bmdnq7bXWgd4VkemW2aX;u NHPwOFkyOjd2NUC4NC=>
C2C12 MX\GeY5kfGmxbjDBd5NigQ>? MVOxNOKh|ryP NEDhUXU3KGh? NYLZPY9HWHKndnXueJMhfGinIIPldolv\SCyaH;zdIhwenmuYYTpc44hd2ZiSWLTMVEhcW6mdXPl[EBjgSCrboP1cIlvKGGwZD;vdkBVVkZvzsG= M4PoRVE3OjZ5MUK0
PC 12 MojQSpVv[3Srb36gRZN{[Xl? MmHqNVDDqM7:TR?= M1r0eVI1KGh? MnPwRZR1\W63YYTld{Bk[XSnY3jvcIFucW6nIHLpc5N6dnSqZYPpdy=> NHLYUJIyPjJzOUSyOC=>
Cynomolgus monkey embryonic stem cells MnS4R5l1d3SxeHnjJGF{e2G7 M17nWVIxKML3TR?= MU[yOEBp NUDITZZlWHKxbX;0[ZMh[3mHUzDj[YxtKHO3co\peoFt M{O2bVE5QTRyOEW1
TSGH 8301 MV;NbYdz[XSrb36gRZN{[Xl? NH\JRoEzOCEEtV2= NEe1RWsyKGh? MonlTY5kemWjc3XzJINmdGxibXnndoF1cW:w MYOxPVg6PjR5NR?=
Swiss3T3 MlHIR49td267LX\vdo1qdmdiQYPzZZk> NWH5NGF1OTBiwsXN NV3ufoo1OTNiZB?= MYPJcoNz\WG|ZYOgdJJwe3SjdHWgZ4VtdCClb3zvcpku\m:{bXnu[{Bi[3Srdnn0fS=> NXjhZXRROjF2NkS5NFI>
HT22 NE[yPWxEgXSxdH;4bYMhSXO|YYm= NUnsSVlROTBiwsXN MmDHNVMhcA>? NIW2VXhRem:2ZXP0d{Bi\2GrboP0JIdtfXSjbXH0[U1qdmS3Y3XkJI5mfXKxbnHsJIRm[XSq MnrONlI5OTB6M{W=
Salivary gland stem cells MUDGeY5kfGmxbjDBd5NigQ>? M{LHWlExKML3TR?= NUjhfWlHPyCm NVv1b5g1WmWmdXPld{BUT1OFIIPlcoV{[2WwY3W= M2XzfVI2QDB2NU[w

多くの細胞株試験データを見る場合、クリックしてください

体内試験 Oral administration of Y-27632 2HCl at 30 mg/kg significantly decreases the blood pressure in a dose-dependent manner in spontaneous hypertensive rats, renal hypertensive rats, as well as deoxycorticosterone acetate (DOCA)-salt hypertensive rats. [1] When Y-27632 2HCl is continuously administered at a rate of 0.55 μL per hour by implanted pumps for 11 days tumor cell invasion (MM1 cells expressing Val14-RhoA in rats) is significantly delayed. [2] By inhibiting ROCK, Y-27632 2HCl treatment attenuates hypoxia-induced angiogenesis and vascular remodeling in the pulmonary circulation. [5] Pretreatment with Y-27632 has a protective effect against tumor formation in albino mice with Ehrlich ascites carcinoma. [7]

お薦めの試験操作(参考用のみ)

動物試験:[1] [7]
+ 展開
  • 動物モデル: Male Wistar rats with spontaneous or induced hypertension; Swiss albino mice with Ehrlich ascites carcinoma
  • 製剤: Dissolved in DMSO, and diluted in saline (Rat); 0.9% NaCl (Mice)
  • 投薬量: 30 mg/kg/day (Rat); 0-10 mg/kg (mice)
  • 投与方法: Orally (Rat); i.p. (Mice)
    (参考用のみ)

溶解度 (25°C)

体外 DMSO 64 mg/mL (199.83 mM) warming
Water 14 mg/mL (43.71 mM)
Ethanol Insoluble
体内 左から(NMPから)右の順に溶剤を製品に加えます:
saline
混合させたのち直ちに使用することを推奨します。
10mg/mL

* 溶解度測定はSelleck技術部門によって行われており、その他文献に示されている溶解度と差異がある可能性がありますが、同一ロットの生産工程で起きる正常な現象ですからご安心ください。

化学情報

分子量 320.26
化学式

C14H21N3O.2HCl

CAS No. 129830-38-2
保管
別名 N/A

便利ツール

モル濃度計算器

モル濃度計算器

解決のために必要とされるマス、ボリュームまたは濃度を計算してください。

マス (g) = 濃度 (mol/L) x ボリューム (L) x 分子量 (g/mol)

モル濃度計算器方程式

  • マス
    濃度
    ボリューム
    分子量

*貯蔵液を準備するとき、常に、オンであるとわかる製品のバッチに特有の分子量を使って、を通してラベルとMSDS/COA(製品ページで利用可能な)。

希釈計算器

希釈計算器

貯蔵液を準備することを要求される希釈剤を計算してください. セレック希釈計算器は、以下の方程式に基づきます:

開始濃度 x 開始体積 = 最終濃度 x 最終体積

希釈の計算式

この方程式は、一般に略語を使われます:C1V1 = C2V2 ( 輸入 輸出 )

  • C1
    V1
    C2
    V2

常に貯蔵液を準備するとき、小びんラベルとMSDS/COA(オンラインで利用できる)で見つかる製品のバッチに特有の分子量を使ってください。

連続希釈計算器方程式

  • 連続希釈剤

  • 計算結果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量計算器

分子量计算器

そのモル質量と元素組成を計算するために、合成物の化学式を入力してください:

総分子量:g/mol

チップス: 化学式は大文字と小文字の区別ができます。C10H16N2O2 c10h16n2o2

モル濃度計算器

マス 濃度 ボリューム 分子量

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

  • * 必須

よくある質問(FAQ)

  • 質問1:

    Is there any data about the Amax (maximum attraction luminosity) and extinction coefficient of this compound?

  • 回答:

    The wavelength we used to test HPLC is 260nm while the extinction coefficient is unknown.

  • 質問2:

    Could this product be used in cell culture? Do you have any reference for this application?

  • 回答:

    Yes. The Y-27632 can be used in cell culture certainly. Here is the reference website: http://molpharm.aspetjournals.org/content/57/5/976.full.

ROCKシグナル伝達経路

ROCK Inhibitors with Unique Features

相関ROCK製品

Tags: Y-27632 2HClを買う | Y-27632 2HCl ic50 | Y-27632 2HCl供給者 | Y-27632 2HClを購入する | Y-27632 2HCl費用 | Y-27632 2HCl生産者 | オーダーY-27632 2HCl | Y-27632 2HCl化学構造 | Y-27632 2HCl分子量 | Y-27632 2HCl代理店
×
細胞株 試験類型 濃度 培養時間 溶剤類型 活性叙述 PMID